Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness

NAActive, not recruitingINTERVENTIONAL
Enrollment

21,110

Participants

Timeline

Start Date

November 18, 2021

Primary Completion Date

February 25, 2025

Study Completion Date

March 30, 2026

Conditions
HPV
Interventions
BEHAVIORAL

Brief Provider Training - Bundled Approach

At each clinic randomized to bundled training, providers will be invited to participate in one, in-clinic, group-based training. Each training will last one-hour and providers will receive continuing medical education (CME) credit for participating. Trainings will focus on introducing the HPV vaccine in a bundle of the other two adolescent vaccines (Tdap and MenACWY).

BEHAVIORAL

Brief Provider Training - Benefits Approach

At each clinic randomized to benefits training, providers will be invited to participate in one, in-clinic, group-based training . Each training will last one-hour and providers will receive continuing medical education (CME) credit for participating. Trainings will focus on providers presenting the HPV vaccine as safe, best if received at 11- to 12-years of age, and prevents cancer.

BEHAVIORAL

Parent Interactive Text Message - Bundled Approach

Text messages sent to parents will focus on receiving all three adolescent vaccines.

BEHAVIORAL

Parent Interactive Text Message - Benefits Approach

Text message will state that the HPV vaccine prevents cancer, is safe and effective, and is recommended for 11- to 12-year-olds.

Trial Locations (1)

32610

University of Florida, Gainesville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Florida

OTHER